July 14, 2020 | Blog
Access and Reimbursement: Access to Digital Therapeutics in a Post-COVID-19 World
CBPartners’ in collaboration with Eric Bernath, explores the current USA access landscape, processes and pitfalls for companion digital therapeutics (DTx), as well as how the space is likely to evolve in the future, and lays out some best practices as suggested by USA payers to maximize chances of reimbursement.